Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone-Salmeterol to Treat Chronic Obstructive Pulmonary Disease

CONCLUSION: Use of generic and brand-name fluticasone-salmeterol was associated with similar outcomes among patients with COPD treated in routine practice.PRIMARY FUNDING SOURCE: National Heart, Lung, and Blood Institute.PMID:37549393 | DOI:10.7326/M23-0615

Source: Annals of Internal Medicine - August 7, 2023 Category: Internal Medicine Authors: William B Feldman Aaron S Kesselheim Jerry Avorn Massimiliano Russo Shirley V Wang Source Type: research